Sedation Reversal
Sedation Reversal is a pharmacological intervention that belongs to the class of antidotal therapies and is specifically characterized by the targeted antagonism of benzodiazepine-induced central nervous system depression through the competitive inhibition of benzodiazepine receptors, as exemplified by the administration of flumazenil.
109
Publications
3.9K
Citations
406
Authors
156
Institutions
Publications per year
2017–2026
6
Parents
109
Cándido Hernández-López, Magı́ Farré, Pere N. Roset et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 192 citations
1–5 of 109
406
3
h-index
The University of Texas Southwestern Medical Center, United States
3 publications · 177 citations
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 406
156

Manchester Royal Infirmary
Manchester, United Kingdom
4 h-index
5 publications
324 citations

University of Hong Kong
Pok Fu Lam, Hong Kong
3 h-index
5 publications
190 citations

Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
3 h-index
9 publications
206 citations

Thomas Jefferson University
Philadelphia, United States
2 h-index
4 publications
176 citations
Addenbrooke's Hospital
Cambridge, United Kingdom
2 h-index
6 publications
180 citations

University of Georgia
Athens, United States
2 h-index
10 publications
292 citations
The University of Texas Southwestern Medical Center
Dallas, United States
2 h-index
2 publications
115 citations

University of Turku
Turku, Finland
2 h-index
6 publications
434 citations
1–8 of 156
Repository · 16 publications · 494 citations
13
h-index
8 publications · 345 citations
8
h-index
7 publications · 318 citations
7
h-index
7 publications · 312 citations
7
h-index
4 publications · 127 citations
4
h-index
1–5